Updates on glioblastoma multiforme: From epidemiology to imaging and artificial intelligence

doi:10.35711/aimi.v6.i2.108032

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 6, Issue 2

This Article

(75)

(71)

(0)

(38)

(1)

(3095)

(1)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

Artificial Intelligence in Medical Imaging

ISSN

2644-3260

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

Artif Intell Med Imaging. Sep 8, 2025; 6(2): 108032
Published online Sep 8, 2025. doi: 10.35711/aimi.v6.i2.108032

Table 1 Macdonald criteria for treatment response based on major changes in tumor size on computed tomography or magnetic resonance imaging images[66]

Response	Criteria
Complete response	Complete disappearance of disease and no new lesions
Partial response	≥ 50% decrease compared with baseline volume and no new lesions
Stable disease	Does not qualify for complete response, partial response, or progression; clinically stable
Progression	≥ 25% increase of the baseline volume, any new lesion, or clinical deterioration

Full Size Table

Citation: Bentourkia M, Abdo RA. Updates on glioblastoma multiforme: From epidemiology to imaging and artificial intelligence. Artif Intell Med Imaging 2025; 6(2): 108032
URL: https://www.wjgnet.com/2644-3260/full/v6/i2/108032.htm
DOI: https://dx.doi.org/10.35711/aimi.v6.i2.108032

Bentourkia M, Abdo RA. Updates on glioblastoma multiforme: From epidemiology to imaging and artificial intelligence. Artif Intell Med Imaging 2025; 6(2): 108032 [DOI: 10.35711/aimi.v6.i2.108032]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.